Search Results - "Weaver, J U"

Refine Results
  1. 1
  2. 2

    Severe hyponatraemia: investigation and management in a district general hospital by Saeed, B O, Beaumont, D, Handley, G H, Weaver, J U

    Published in Journal of clinical pathology (01-12-2002)
    “…Aims: To study the incidence, investigation, and management of severe hyponatraemia (serum sodium < 120 mmol/litre) over a period of six months in a district…”
    Get full text
    Journal Article
  3. 3

    The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults by Weaver, J U, Monson, J P, Noonan, K, John, W G, Edwards, A, Evans, K A, Cunningham, J

    “…GH deficiency is associated with increased cardiovascular morbidity, which may be determined by alterations in vascular risk factors. We report the effect of…”
    Get more information
    Journal Article
  4. 4

    The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study by Drake, W. M., Rodríguez-Arnao, J., Weaver, J. U., James, I. T., Coyte, D., Spector, T. D., Besser, G. M., Monson, J. P.

    Published in Clinical endocrinology (Oxford) (01-04-2001)
    “…OBJECTIVES The objectives of this study were to investigate the effects of GH replacement therapy in hypopituitary adults with growth hormone deficiency (GHD)…”
    Get full text
    Journal Article
  5. 5

    Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism by McMillan, C V, Bradley, C, Woodcock, A, Razvi, S, Weaver, J U

    Published in Thyroid (New York, N.Y.) (01-11-2004)
    “…This paper reports work undertaken to design two new condition-specific questionnaires for use in hypothyroidism: the Underactive Thyroid-Dependent Quality of…”
    Get more information
    Journal Article
  6. 6

    Serum fructosamine as a marker of 5-year risk of developing diabetes mellitus in patients exhibiting stress hyperglycaemia by Wahid, S. T., Sultan, J., Handley, G., Saeed, B. O., Weaver, J. U., Robinson, A. C. J.

    Published in Diabetic medicine (01-07-2002)
    “…Aims We examined whether the level of random serum glucose (RSG) in subjects exhibiting stress hyperglycaemia is a useful marker of the future risk of…”
    Get full text
    Journal Article
  7. 7

    Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study by TAYLOR, Roy, DAVIES, Robert, FOX, Charles, SAMPSON, Michael, WEAVER, Jola U, WOOD, Linda

    Published in Diabetes care (01-11-2000)
    “…Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study. R Taylor , R Davies , C Fox , M Sampson , J U Weaver and L Wood…”
    Get full text
    Journal Article
  8. 8

    Sexual dimorphism in 11 β hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects by Weaver, Jolanta U, Taylor, Norman F, Monson, John P, Wood, Peter J, Kelly, William F

    Published in Clinical endocrinology (Oxford) (01-07-1998)
    “…OBJECTIVE Sexual dimorphism of 11 β hydroxysteroid dehydrogenase activity (11 β HSD) as measured by the urinary 11‐OH/11‐oxo cortisol metabolite ratio has been…”
    Get full text
    Journal Article
  9. 9

    Influence of growth hormone on accretion of bone mass by Monson, J P, Drake, W M, Carroll, P V, Weaver, J U, Rodriguez-Arnao, J, Savage, M O

    Published in Hormone research (2002)
    “…Growth hormone (GH) exerts important influences on bone metabolism during lifespan. During childhood, GH is a major determinant of acquisition of bone mass and…”
    Get more information
    Journal Article
  10. 10

    Nateglinide alone or with metformin safely improves glycaemia to target in patients up to an age of 84 by Weaver, J. U., Robertson, D., Atkin, S. L.

    Published in Diabetes, obesity & metabolism (01-09-2004)
    “…Aim:  To assess the effect of nateglinide on efficacy [fasting plasma glucose (FPG), postprandial plasma glucose (PPG) plasma glucose and HbA1c], tolerability…”
    Get full text
    Journal Article
  11. 11

    Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA1c in insulin-treated diabetes (MITRE Study) by Cooke, D., Hurel, S. J., Casbard, A., Steed, L., Walker, S., Meredith, S., Nunn, A. J., Manca, A., Sculpher, M., Barnard, M., Kerr, D., Weaver, J. U., Ahlquist, J., Newman, S. P.

    Published in Diabetic medicine (01-05-2009)
    “…Aims  To determine whether continuous glucose information provided through use of either the GlucoWatch G2 Biographer or the MiniMed continuous glucose…”
    Get full text
    Journal Article
  12. 12

    Central obesity and hyperinsulinaemia in women are associated with polymorphism in the 5' flanking region of the human insulin gene by Weaver, J U, Kopelman, P G, Hitman, G A

    Published in European journal of clinical investigation (01-04-1992)
    “…Obesity is a multifactorial disease with a marked genetic component. The situation is further complicated by the heterogeneity of obesity demonstrated by the…”
    Get more information
    Journal Article
  13. 13

    Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity by Weaver, J U, Holly, J M, Kopelman, P G, Noonan, K, Giadom, C G, White, N, Virdee, S, Wass, J A

    Published in Clinical endocrinology (Oxford) (01-09-1990)
    “…Obesity may be characterized by abnormal sex steroid secretion and reduced sex hormone binding globulin (SHBG) which in turn is related to fat distribution and…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Applicability of estimated glomerular filtration rate in stratifying chronic kidney disease by Khatami, Z., Handley, G., Narayanan, K., Weaver, J. U.

    “…Objective. The aim of this audit was to evaluate the degree of glomerular filtration rate (GFR) among inpatients and outpatients in a District General…”
    Get full text
    Journal Article
  16. 16
  17. 17

    An association between hypothalamic-pituitary dysfunction and peripheral endocrine function in extreme obesity by Weaver, J U, Noonan, K, Kopelman, P G

    Published in Clinical endocrinology (Oxford) (01-07-1991)
    “…The aim was to investigate a possible relationship between measures of insulin secretion and glucose disposal and hypothalamic-pituitary function in extreme…”
    Get more information
    Journal Article
  18. 18

    The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11β-hydroxysteroid dehydrogenase activity by Gelding, S. V., Taylor, N. F., Wood, P. J., Noonan, K., Weaver, J. U., Wood, D. F., Monson, J. P.

    Published in Clinical endocrinology (Oxford) (01-02-1998)
    “…OBJECTIVE Growth hormone (GH) replacement therapy in hypopituitary adults has been associated with a decreased urinary ratio of 11‐hydroxy/11‐oxo‐cortisol…”
    Get full text
    Journal Article
  19. 19

    Impaired prolactin secretion and body fat distribution in obesity by Weaver, J U, Noonan, K, Kopelman, P G, Coste, M

    Published in Clinical endocrinology (Oxford) (01-05-1990)
    “…Human obesity shows clustering within families. The hypothesis for the presence of a major gene or genes acting in human obesity is supported by recent…”
    Get more information
    Journal Article
  20. 20